CONTEXT: Neuropeptide Y (NPY) counters stress and is involved in neuroadaptations that drive escalated alcohol drinking in rodents. In humans, low NPY expression predicts amygdala response and emotional reactivity. Genetic variation that affects the NPY system could moderate stress resilience and susceptibility to alcohol dependence. OBJECTIVE: To determine whether functional NPY variation influences behavioral adaptation to stress and alcohol consumption in a nonhuman primate model of early adversity (peer rearing). DESIGN: We sequenced the rhesus macaque NPY locus (rhNPY) and performed in silico analysis to identify functional variants. We performed gel shift assays using nuclear extract from testes, brain, and hypothalamus. Levels of NPY in cerebrospinal fluid were measured by radioimmunoassay, and messenger RNA levels were assessed in the amygdala using real-time polymerase chain reaction. Animals were exposed to repeated social separation stress and tested for individual differences in alcohol consumption. Animals were genotyped for -1002 T > G, and the data were analyzed using analysis of variance. SETTING: National Institutes of Health Animal Center. Subjects Ninety-six rhesus macaques. Main Outcome Measure Behavior arousal during social separation stress and ethanol consumption. RESULTS: The G allele altered binding of regulatory proteins in all nuclear extracts tested, and -1002 T > G resulted in lower levels of NPY expression in the amygdala. Macaques exposed to adversity had lower cerebrospinal fluid NPY levels and exhibited higher levels of arousal during stress, but only as a function of the G allele. We also found that stress-exposed G allele carriers consumed more alcohol and exhibited an escalation in intake over cycles of alcohol availability and deprivation. CONCLUSIONS: Our results suggest a role for NPY promoter variation in the susceptibility to alcohol use disorders and point to NPY as a candidate for examining gene x environment interactions in humans.
CONTEXT: Neuropeptide Y (NPY) counters stress and is involved in neuroadaptations that drive escalated alcohol drinking in rodents. In humans, low NPY expression predicts amygdala response and emotional reactivity. Genetic variation that affects the NPY system could moderate stress resilience and susceptibility to alcohol dependence. OBJECTIVE: To determine whether functional NPY variation influences behavioral adaptation to stress and alcohol consumption in a nonhuman primate model of early adversity (peer rearing). DESIGN: We sequenced the rhesus macaqueNPY locus (rhNPY) and performed in silico analysis to identify functional variants. We performed gel shift assays using nuclear extract from testes, brain, and hypothalamus. Levels of NPY in cerebrospinal fluid were measured by radioimmunoassay, and messenger RNA levels were assessed in the amygdala using real-time polymerase chain reaction. Animals were exposed to repeated social separation stress and tested for individual differences in alcohol consumption. Animals were genotyped for -1002 T > G, and the data were analyzed using analysis of variance. SETTING: National Institutes of Health Animal Center. Subjects Ninety-six rhesus macaques. Main Outcome Measure Behavior arousal during social separation stress and ethanol consumption. RESULTS: The G allele altered binding of regulatory proteins in all nuclear extracts tested, and -1002 T > G resulted in lower levels of NPY expression in the amygdala. Macaques exposed to adversity had lower cerebrospinal fluid NPY levels and exhibited higher levels of arousal during stress, but only as a function of the G allele. We also found that stress-exposed G allele carriers consumed more alcohol and exhibited an escalation in intake over cycles of alcohol availability and deprivation. CONCLUSIONS: Our results suggest a role for NPY promoter variation in the susceptibility to alcohol use disorders and point to NPY as a candidate for examining gene x environment interactions in humans.
Authors: A J Bennett; K P Lesch; A Heils; J C Long; J G Lorenz; S E Shoaf; M Champoux; S J Suomi; M V Linnoila; J D Higley Journal: Mol Psychiatry Date: 2002 Impact factor: 15.992
Authors: Olga V Kel-Margoulis; Alexander E Kel; Ingmar Reuter; Igor V Deineko; Edgar Wingender Journal: Nucleic Acids Res Date: 2002-01-01 Impact factor: 16.971
Authors: C A Morgan; S Wang; S M Southwick; A Rasmusson; G Hazlett; R L Hauger; D S Charney Journal: Biol Psychiatry Date: 2000-05-15 Impact factor: 13.382
Authors: Christopher M Mayer; Fang Cai; Hong Cui; Julia M A Gillespie; Meeka MacMillan; Denise D Belsham Journal: Biochem Biophys Res Commun Date: 2003-08-08 Impact factor: 3.575
Authors: J Kasckow; J J Mulchahey; G Aguilera; M Pisarska; M Nikodemova; H-C Chen; J P Herman; E K Murphy; Y Liu; T A Rizvi; F M Dautzenberg; S Sheriff Journal: J Neuroendocrinol Date: 2003-05 Impact factor: 3.627
Authors: Jaakko Lappalainen; Henry R Kranzler; Robert Malison; Lawrence H Price; Christopher Van Dyck; Robert A Rosenheck; Joyce Cramer; Steven Southwick; Dennis Charney; John Krystal; Joel Gelernter Journal: Arch Gen Psychiatry Date: 2002-09
Authors: Richard Lieberman; Stephen Armeli; Denise M Scott; Henry R Kranzler; Howard Tennen; Jonathan Covault Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2016-05-19 Impact factor: 3.568
Authors: Stephen G Lindell; Qiaoping Yuan; Zhifeng Zhou; David Goldman; Robert C Thompson; Juan F Lopez; Stephen J Suomi; J Dee Higley; Christina S Barr Journal: Dev Psychopathol Date: 2012-11